Chapter 19: Basic Concepts in the Regulation of Fuel Metabolism by Insulin, Glucagon, and Other Hormones

The core principle is metabolic homeostasis, achieved through the coordinated actions of insulin and glucagon, which operate as opposing regulators of nutrient storage and mobilization. Insulin, released by pancreatic beta cells in response to elevated blood glucose after meals, functions as the primary anabolic hormone by promoting glucose uptake into muscle and adipose tissue, glycogen synthesis in liver and muscle, triacylglycerol storage in adipose depots, and protein synthesis. Glucagon, secreted by pancreatic alpha cells during fasting or low blood glucose states, acts as the predominant catabolic hormone by triggering glycogenolysis and gluconeogenesis to raise glucose availability, and activating lipolysis to mobilize fatty acids for energy. The chapter details distinct signal transduction mechanisms: insulin activates receptor tyrosine kinase cascades involving IRS-1 and phosphorylation-based enzyme regulation, while glucagon engages G-protein-coupled receptors that increase intracellular cyclic AMP and activate protein kinase A. Counterregulatory hormones including epinephrine, norepinephrine, and cortisol amplify fuel mobilization during stress, exercise, and prolonged fasting by opposing insulin effects and enhancing both gluconeogenesis and lipolysis. The pathophysiology of metabolic disease is illustrated through clinical scenarios: type 2 diabetes arising from insulin resistance and impaired glucose tolerance, type 1 diabetes resulting from autoimmune destruction of insulin-producing cells, and insulinomas causing severe hypoglycemia through excessive insulin secretion. Complications of dysregulated glucose metabolism are explored, including osmotic diuresis and hyperglycemic hyperosmolar states from sustained hyperglycemia, hemoglobin glycosylation as a marker of long-term glucose control, and chronic diabetic complications affecting the retina, kidneys, peripheral nerves, and cardiovascular system. The chapter also addresses monogenic forms of diabetes such as MODY caused by glucokinase mutations and neonatal diabetes linked to mutations in potassium channel genes, highlighting the genetic basis of metabolic regulation. Understanding these regulatory systems is essential for comprehending how the body integrates nutrient availability with energy demand across fed and fasted states.